Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis

por Bjørnhart, Birgitte, Hansen, Karin Holmskov, Asmussen, Jon Thor, Jørgensen, Trine Lembrecht, Herrstedt, Jørn, Schytte, Tine
Publicado 2022

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy

por Mouritzen, Mette T., Carus, Andreas, Ladekarl, Morten, Meldgaard, Peter, Nielsen, Anders W. M., Livbjerg, Anna, Larsen, Jacob W., Skuladottir, Halla, Kristiansen, Charlotte, Wedervang, Kim, Schytte, Tine, Hansen, Karin H., Østby, Anne-Cathrine, Frank, Malene S., Lauritsen, Jakob, Sørensen, Jens B., Langer, Seppo W., Persson, Gitte F., Andersen, Jon L., Frary, Johanna M. C., Drivsholm, Lars B., Vesteghem, Charles, Christensen, Heidi S., Bjørnhart, Birgitte, Pøhl, Mette
Publicado 2021